Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 29082K105 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
American Century Investment Management, Inc.
13G/A
Amendment 5
|
0% |
8/14/2026
Event 6/30/2026
|
|
| American Century Investment Management, Inc. | 0% | ||
| American Century Companies, Inc. | 0% | ||
| Stowers Institute for Medical Research | 0% | ||
| BlackRock, Inc. 13G/A Amendment 5 | 7.7% |
7/8/2026
Event 6/30/2026
|
|
| River Road Asset Management, LLC 13G/A Amendment 1 | 0% |
5/27/2026
Event 5/26/2026
|
|
|
Yacktman Asset Management LP
13G
|
6.2% |
5/5/2026
Event 3/31/2026
|
|
| Yacktman Asset Management LP | 6.2% | ||
| Amg Yacktman Fund | 5.1% | ||
|
American Century Investment Management, Inc.
13G/A
Amendment 4
|
5.8% |
5/1/2026
Event 3/31/2026
|
|
| American Century Capital Portfolios, Inc. | 3.4% | ||
| American Century Investment Management, Inc. | 5.8% | ||
| American Century Companies, Inc. | 5.8% | ||
| Stowers Institute for Medical Research | 5.8% | ||
| Vanguard Capital Management LLC 13G | 5.1% |
4/29/2026
Event 3/31/2026
|
|
| Vanguard Group Inc 13G/A Amendment 5 | 0% |
3/26/2026
Event 3/13/2026
|
|
| Vanguard Group Inc 13G/A Amendment 4 | 7.8% |
1/30/2026
Event 12/31/2025
|
|
|
American Century Investment Management, Inc.
13G/A
Amendment 3
|
8.9% |
8/14/2025
Event 6/30/2025
|
|
| American Century Capital Portfolios, Inc. | 5.9% | ||
| American Century Investment Management, Inc. | 8.9% | ||
| American Century Companies, Inc. | 8.9% | ||
| Stowers Institute for Medical Research | 8.9% | ||
| Vanguard Group Inc 13G/A Amendment 3 | 9.4% |
7/29/2025
Event 6/30/2025
|
|
| BlackRock, Inc. 13G/A Amendment 4 | 15.0% |
7/18/2025
Event 6/30/2025
|
|
|
American Century Investment Management, Inc.
13G/A
Amendment 2
|
7.4% |
5/15/2025
Event 3/31/2025
|
|
| American Century Capital Portfolios, Inc. | 5.0% | ||
| American Century Investment Management, Inc. | 7.4% | ||
| American Century Companies, Inc. | 7.4% | ||
| Stowers Institute for Medical Research | 7.4% | ||
|
James E. Flynn
13G/A
Amendment 1
|
4.7% |
5/13/2025
Event 3/31/2025
|
|
| Deerfield Mgmt, L.P. | 4.7% | ||
| Deerfield Management Company, L.P. | 4.7% | ||
| Deerfield Partners, L.P. | 4.7% | ||
| James E. Flynn | 4.7% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 14 | 17.6 k | $99.6 k |
| 2026 Q2 | 329 | 50.5 M | $224 M |
| 2026 Q1 | 351 | 60.6 M | $536 M |
| 2025 Q4 | 380 | 58.2 M | $692 M |
| 2025 Q3 | 372 | 56.6 M | $797 M |
| 2025 Q2 | 372 | 58.1 M | $565 M |
| 2025 Q1 | 382 | 57.1 M | $728 M |
| 2024 Q4 | 387 | 55.5 M | $1.15 B |
| 2024 Q3 | 381 | 54.8 M | $773 M |
| 2024 Q2 | 378 | 56.9 M | $710 M |
| 2024 Q1 | 387 | 56.8 M | $755 M |
| 2023 Q4 | 389 | 57.1 M | $1.08 B |
| 2023 Q3 | 388 | 56.5 M | $851 M |
| 2023 Q2 | 414 | 54.1 M | $1.17 B |
| 2023 Q1 | 446 | 55.7 M | $1.57 B |
| 2022 Q4 | 460 | 65.6 M | $1.66 B |
| 2022 Q3 | 475 | 56.2 M | $1.62 B |
| 2022 Q2 | 498 | 54.7 M | $1.39 B |
| 2022 Q1 | 39 | 3.77 M | $116 M |
| 2021 Q3 | 1 | 48.0 | $1.00 k |